Stage IV Bladder Cancer AJCC v6

Known as: carcinoma of the bladder, stage IV, Jewett-Marshall Stage D Urinary Bladder Cancer, bladder cancer, metastatic 
Stage IV includes the following: T4b, N0, M0; Any T, N1, M0; Any T, N2 M0; Any T, N3 M0; Any T, Any N, M1. T4b: Tumor invades the pelvic wall… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
CONTEXT Invasive bladder cancer is a frequently occurring disease with a high mortality rate despite optimal treatment. The… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2016
Highly Cited
2016
BACKGROUND At least half of the patients diagnosed with non-muscle-invasive bladder cancer (NMIBC) experience recurrence and… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2012
2012
Overexpression of CD24, a glycosyl phosphatidylinositol-linked sialoglycoprotein, is associated with poor outcome in urothelial… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Half of patients treated for locally advanced bladder cancer relapse with often fatal metastatic disease to the lung. We have… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2005
2005
We previously identified MIM-A (missing in metastasis, MTSS1) by differential display techniques as missing in invasive… (More)
Is this relevant?
2004
2004
Pulmonary metastases frequently develop in patients with aggressive bladder cancer, yet investigation of this process at the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
2001
2001
PURPOSE We update our experience with post-chemotherapy surgery in patients with unresectable or lymph node positive bladder… (More)
Is this relevant?
1999
1999
PURPOSE Although transitional cell carcinoma of the bladder (TCC) metastasizes frequently with devastating consequences, no… (More)
Is this relevant?
1994
1994
BACKGROUND Gemcitabine (2'2-difluorodeoxycytidine; GEM) is a novel deoxycytidine analogue with promising antitumor activity… (More)
Is this relevant?